… In conclusion, our study developed and validated an individualized diagnostic signature in
… , our study developed and validated an individualized diagnostic signature in thyroid cancer. …

… have developed ML models for predicting death or recurrence in patients with thyroid cancer
[18,… Thus, this study aimed to develop and validate multiple ML models to predict structural …

… previously developed Cancer … all cancer patients, it still lacks specificity for thyroid cancer
(21). Therefore, the purpose of our study was to develop and validate a specific Thyroid Cancer …

… develop a predictive tool to predict cancer-specific survival (CSS) in middle-aged patients with
papillary thyroid … mutation is usually considered to be the first step in cancer development [ …

Background Anaplastic thyroid cancer (ATC) is a highly aggressive malignancy with dismal
prognosis. This study aimed to identify the independent risk factors and construct a readily-to-…

… Objective: This study aimed to establish and validate the nomograms for predicting overall
survival (OS) probabilities in differentiated thyroid cancer (DTC) patients who received and …

… Papillary thyroid carcinoma (PTC) accounts for more than 80% of thyroid cancers. Accurate
… We aimed to construct a nomogram predicting cancer-specific survival (CSS) in elderly …

… M stage in the prediction of survival probability of thyroid cancer. Our study was conducted
in patients with distant metastatic differentiated thyroid cancer (M1), age < 55 years defines …

… of thyroid cancer. , 2 , 3 Herein, we present a two‐step study to develop and validate an …
on circulating tumor cells (CTCs) signatures for papillary thyroid cancer (PTC) diagnosis. …

… influence the carcinogenesis of thyroid cancer (THCA), the … developed and validated a
prognostic model based on m6A-related lncRNAs and mRNAs in THCA. Data from the Cancer …